nLIGHT CEO Sells 31,748 Shares as Company Reveals Q4 Revenue Topped Guidance

nLIGHT CEO Scott Keeney exercised and immediately sold 31,748 options on Jan. 6 for roughly $1.19M (weighted average $37.51), representing 1.37% of his direct holdings and leaving him with 2,285,020 directly held shares (approx. $86.1M). The trade was executed under a prearranged Rule 10b5-1 plan and involved no indirect entities; it is characterized as routine liquidity/tax planning rather than a change in outlook. Separately, management preannounced Q4 2025 revenue of $78M–$80M, above prior guidance, supporting constructive operational momentum as the company leverages laser and directed-energy demand across commercial and defense markets; market cap is ~$2.05B with TTM revenue of $227.53M.

Analysis

Market structure: The insider option exercise/sale is liquidity/tax-driven and neutral for immediate supply; CEO retains ~2.285M shares (~$86M value) so alignment remains. nLIGHT (LASR, $37.51, $2.05B market cap) is benefiting from defense-directed-energy and sensing demand (Q4 preannounce $78–80M > guidance), which should increase pricing power in high-power fiber/semiconductor lasers versus smaller competitors; expect 5–15% revenue upside risk if DoD awards materialize in next 6–12 months.

Risk assessment: Tail risks include loss of major DoD program awards, export controls/China market restrictions, or a rapid end-market industrial slowdown; any one could depress revenue by >20% YoY. Near-term (days–weeks) volatility is low; short-term (3–6 months) hinges on contract wins and FY26 guidance cadence; long-term (12–36 months) depends on product mix shift to defense and margin expansion to >20% EBITDA. Monitor insider selling >5% of direct holdings over 90 days and any guidance revision >±5% as triggers.

Trade implications: Direct long: establish a 2–3% portfolio position in LASR (buy shares) targeting 40–60% upside over 12 months if directed-energy awards continue; set stop-loss at -15% or $32. Long/short pair: long LASR vs short IPGP to isolate company-specific execution (size 1:0.6 by market cap exposure). Options: buy 12–18 month LEAP calls (e.g., Jan 2027 45C) or a 45/60 call spread financed by selling 3–6 month calls to collect premium.

Contrarian angles: The market underprices nLIGHT’s defense optionality—consensus may not fully embed multi-year DoD programs (could double defense revenue contribution from ~current mix to +20–30% of sales). Conversely, upside is capped if export restrictions or a competitor (IPGP) wins large share; this asymmetry favors defined-risk options (buying LEAP calls or call spreads) over outright jumbo leverage. Historical parallel: small-cap defense suppliers rerated 40–120% post-contract wins within 6–9 months; use contract-award dates as liquidity events to add or trim positions.

Key Decisions for Investors

• Establish a 2–3% long position in LASR (buy shares at market up to $38.50) with a 12-month target of +50% and a hard stop-loss at -15% (~$32).
• Position a directional options trade: buy Jan 2027 LEAP 45C (or nearest delta ~0.35) sized to equal 50% of the cash position; alternatively use a 45/60 call spread to cap cost, sell 3–6 month calls to finance 30–40% of premium.
• Construct a relative-value pair: long LASR (size X) / short IPGP (size 0.6X by market-cap exposure) to play company-specific defense share gains; close or rebalance after major DoD awards (6–12 months).
• Immediate risk controls: liquidate or cut LASR exposure by 50% if (a) CEO/insider cumulative selling >5% direct holdings within 90 days, or (b) next quarterly guidance misses consensus by >5%; monitor DoD contract announcements and export-control headlines on a weekly basis for 6 months.